Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Equities research analysts predict that Bath & Body Works, Inc. (NYSE:BBWI - Get Rating) will announce $1.43 billion in sales for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Bath & Body Works' earnings, with estimates ranging from $1.42 billion to $1.44 billion. Bath & Body Works posted sales of $3.02 billion during the same quarter last year, which suggests a negative year over year growth rate of 52.6%. The company is scheduled to announce its next earnings report on Monday, January 1st.

According to Zacks, analysts expect that Bath & Body Works will report full-year sales of $8.12 billion for the current fiscal year, with estimates ranging from $8.04 billion to $8.19 billion. For the next fiscal year, analysts forecast that the business will report sales of $8.70 billion, with estimates ranging from $8.43 billion to $8.92 billion. Zacks Investment Research's sales averages are a mean average based on a survey of sell-side research analysts that follow Bath & Body Works.

Bath & Body Works (NYSE:BBWI - Get Rating) last issued its quarterly earnings data on Tuesday, February 22nd. The company reported $2.30 earnings per share for the quarter, beating analysts' consensus estimates of $2.27 by $0.03. The firm had revenue of $3.03 billion during the quarter, compared to analyst estimates of $2.96 billion. Bath & Body Works had a negative return on equity of 115.32% and a net margin of 14.13%. Bath & Body Works's quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.96 EPS.

Several research analysts have recently commented on the company. The Goldman Sachs Group upgraded Bath & Body Works from a "buy" rating to a "conviction-buy" rating in a research report on Wednesday, January 19th. Credit Suisse Group decreased their target price on Bath & Body Works from $69.00 to $64.00 and set a "neutral" rating for the company in a research report on Friday, February 25th. Telsey Advisory Group decreased their target price on Bath & Body Works from $91.00 to $70.00 and set an "outperform" rating for the company in a research report on Thursday, February 24th. Citigroup decreased their target price on Bath & Body Works from $100.00 to $93.00 and set a "buy" rating for the company in a research report on Friday, January 7th. Finally, JPMorgan Chase & Co. cut their price target on Bath & Body Works from $105.00 to $81.00 and set an "overweight" rating on the stock in a report on Thursday, February 24th. Three analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of "Buy" and an average price target of $80.28.

Shares of BBWI opened at $49.90 on Thursday. The firm has a market cap of $11.92 billion, a price-to-earnings ratio of 10.14, a PEG ratio of 1.17 and a beta of 1.80. The stock has a 50 day moving average of $52.36 and a 200-day moving average of $62.96. Bath & Body Works has a 52 week low of $45.46 and a 52 week high of $82.00.

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 4th. Stockholders of record on Friday, February 18th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date of this dividend was Thursday, February 17th. This is an increase from Bath & Body Works's previous quarterly dividend of $0.15. Bath & Body Works's payout ratio is currently 16.26%.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Okabena Investment Services Inc. grew its holdings in shares of Bath & Body Works by 89.2% in the 4th quarter. Okabena Investment Services Inc. now owns 63,451 shares of the company's stock worth $4,428,000 after acquiring an additional 29,916 shares during the last quarter. Norges Bank acquired a new position in shares of Bath & Body Works in the 4th quarter worth $174,496,000. Quent Capital LLC acquired a new position in shares of Bath & Body Works in the 4th quarter worth $97,000. AlphaCentric Advisors LLC acquired a new position in shares of Bath & Body Works in the 4th quarter worth $209,000. Finally, JustInvest LLC grew its holdings in shares of Bath & Body Works by 20.5% in the 4th quarter. JustInvest LLC now owns 5,798 shares of the company's stock worth $405,000 after acquiring an additional 987 shares during the last quarter. Institutional investors and hedge funds own 92.23% of the company's stock.

About Bath & Body Works (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Read MoreGet a free copy of the StockNews.com research report on Bath & Body Works (BBWI)RH Puts The Fear Of Inflation Into The Market3 ESG Friendly Stocks Poised for Green ReturnsFord Insider Bets Big, Buys More Shares 3 Clean Energy Stocks to Buy for a Green FutureLululemon Impresses Wall Street, Get Ready To Buy

Get a free copy of the Zacks research report on Bath & Body Works (BBWI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Each market day you'll get a one-minute market summary to help you invest wisely.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.